Identifying Bone Cancer Response to Treatment
Canine osteosarcoma is a highly aggressive cancer, and despite treatment with surgery followed by chemotherapy, cancer often recurs in other bones or organs, particularly the lungs. This study identifies biomarkers that could indicate how bone cancer will respond to treatment. Results will serve as a basis of a prospective clinical trial to identify tailored chemotherapy treatments for patients.
Dr. Dawn L. Duval, Colorado State University
Co-sponsors: Fla-Coated Retriever Foundation